MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Semaglutide

  • FDA Issues Alert About Overdosing on Weight-Loss Drug After Some Take 5 to 20 Times the Intended Dose
    FDA Issues Alert About Overdosing on Weight-Loss Drug After Some Take 5 to 20 Times the Intended Dose
    Semaglutide is the active ingredient in popular injectable weight-loss drugs.
    July 26, 2024BY Marina Zhang
  • FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    The FDA is also investigating reported side effects of aspiration.
    January 4, 2024BY A.C. Dahnke
  • Semaglutide Poisoning Reports Jump 1,500 Percent as People Accidentally Overdose
    Semaglutide Poisoning Reports Jump 1,500 Percent as People Accidentally Overdose
    Some people have taken 10 times the recommended dose or even the entire month’s dose due to confusion ...
    December 14, 2023BY Naveen Athrappully
  • Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
    December 1, 2023BY Lorenz Duchamps
  • Obesity Drug Wegovy Shows Significant Heart Disease Benefits, but Experts Caution Off-Label Use
    Obesity Drug Wegovy Shows Significant Heart Disease Benefits, but Experts Caution Off-Label Use
    A new class of weight-loss drug shows it can significantly reduce heart disease-related death in people without diabetes.
    November 16, 2023BY George Citroner
  • FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
    FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
    The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs ...
    October 11, 2023BY Lorenz Duchamps
  • Popular Weight Loss Drugs Taken by Millions Hold Highest Safety Warnings
    Popular Weight Loss Drugs Taken by Millions Hold Highest Safety Warnings
    Ozempic and Wegovy may help people lose weight but are associated with a long list of very serious ...
    September 25, 2023BY Megan Redshaw
  • Obesity Drug Wegovy Cuts Heart Risk by 20 Percent: Study
    Obesity Drug Wegovy Cuts Heart Risk by 20 Percent: Study
    The blockbuster weight loss drug Wegovy may reduce heart attack and stroke risk by 20 percent among overweight ...
    August 8, 2023BY George Citroner
  • Assessing Mechanism, Risks of Semaglutide, the Weight Loss Drug Credited by Elon Musk
    Assessing Mechanism, Risks of Semaglutide, the Weight Loss Drug Credited by Elon Musk
    Ozempic and Wegovy, launched by the Danish pharmaceutical company Novo Nordisk, have received much praise on social media ...
    April 19, 2023BY David Chu
  • Ozempic Helps Weight Loss by Making You Feel Full–But Certain Foods Can Do the Same Thing
    Ozempic Helps Weight Loss by Making You Feel Full–But Certain Foods Can Do the Same Thing
    You’ve probably heard about the medication Ozempic, used to manage Type 2 diabetes and as a weight loss ...
    March 24, 2023BY Emma Beckett
  • Wegovy/Ozempic Isn’t a Miracle Drug, It’s Part of the Problem
    Wegovy/Ozempic Isn’t a Miracle Drug, It’s Part of the Problem
    Commentary In October 2022, a fan posted a picture of a noticeably slimmer-looking Elon Musk and asked the ...
    March 16, 2023BY Charles Cornish-Dale
TOP NEWS
  • Cisco Sued in California Over Alleged Link to Human Rights Abuses
    NEW By Eva Fu
    Cisco Sued in California Over Alleged Link to Human Rights Abuses
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    1hr By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    2hr By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    3hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    3hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    4hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
  • Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
    4hr By Evgenia Filimianova
    Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
  • Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
    5hr By Frank Fang
    Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
  • Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
    5hr By Andrew Moran
    Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
  • US Denies Iran’s Claim It Destroyed Radar in Bahrain
    5hr By Evgenia Filimianova
    US Denies Iran’s Claim It Destroyed Radar in Bahrain
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top